Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
about
Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approachesCa(2+) and ion channels in hypoxia-mediated pulmonary hypertensionTranscriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculatureIdentification and functional characterization of protein kinase A-catalyzed phosphorylation of potassium channel Kv1.2 at serine 449.Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodelingEffects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and agonist-induced contraction in rat resistance arteriesHigh-resolution subunit detection of glutamate receptor by ultrasmall gold nanoparticles.Ionic currents in intimal cultured synoviocytes from the rabbit.Kv2 channels oppose myogenic constriction of rat cerebral arteries.Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.Steady-state modulation of voltage-gated K+ channels in rat arterial smooth muscle by cyclic AMP-dependent protein kinase and protein phosphatase 2BHeterogeneity in Kv7 channel function in the cerebral and coronary circulation.Diphenyl phosphine oxide-1-sensitive K(+) channels contribute to the vascular tone and reactivity of resistance arteries from brain and skeletal muscle.Exercise training reverses aging-induced impairment of myogenic constriction in skeletal muscle arterioles.New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.Tacrolimus inhibits vasoconstriction by increasing Ca(2+) sparks in rat aorta.PKC and AMPK regulation of Kv1.5 potassium channelsPathogenic role of store-operated and receptor-operated ca(2+) channels in pulmonary arterial hypertension.Myogenic regulation of arterial diameter: role of potassium channels with a focus on delayed rectifier potassium current.Ion channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage.Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle.Functional Expression Profile of Voltage-Gated K(+) Channel Subunits in Rat Small Mesenteric Arteries.Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation.Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton.Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arteriolesNew tricks for old dogs: KCNQ expression and role in smooth muscle.Determinants of frequency-dependent regulation of Kv1.2-containing potassium channelsAngiotensin II reduces the surface abundance of KV 1.5 channels in arterial myocytes to stimulate vasoconstriction.Triton X-100 inhibits L-type voltage-operated calcium channels.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain.Smooth muscle Ca(2+) -activated and voltage-gated K+ channels modulate conducted dilation in rat isolated small mesenteric arteries.Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteriesIntravascular pressure enhances the abundance of functional Kv1.5 channels at the surface of arterial smooth muscle cells.Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats.Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response.Heterogeneity of hypoxia-mediated decrease in I(K(V)) and increase in [Ca2+](cyt) in pulmonary artery smooth muscle cells.
P2860
Q26996048-22D138E0-2E49-4548-A138-444E2CF23188Q28081804-7612D2E6-0765-4390-A8F4-18E46ED9D90BQ28586649-084B77A1-3872-44D6-AE43-3A31FD8A388BQ33434252-22AF7EDC-3E4C-4EED-8739-DB9F5EB5F972Q33832653-2BF36C2A-5183-4AD0-A34A-5F81442C30A3Q33925149-6D10ADD9-8C54-4ACE-B075-8E58AE0371DFQ34168512-94DAD5A9-BFDF-46FD-A7E0-408011630EA9Q34213500-7164190F-D698-4752-8A89-E3F3EC94F1DEQ34304926-401B5428-1A4F-4A3C-AE48-469A5450AD2FQ34506786-5785DF90-0C3C-4704-AC46-C663E800BCE9Q35128837-03CCF83A-86E3-4718-BB1D-D03405A3CA9AQ35202897-F6767E9E-4BF7-49AC-8545-458DE38534F0Q35538269-FEE240AC-E3F6-4B34-A78A-19053E692DCDQ35547545-535D5648-94C1-4841-A069-A16D8D5CC27FQ35576551-84300F37-803A-48D0-9083-7922136E8D1EQ35900990-F8EF533B-70DA-4B5D-B545-86CD107A8AF2Q35912648-6C758AC5-7D83-4F35-A3F1-06B71C99C003Q36124154-31888038-8AF4-4300-B3EF-4B5E64D6006EQ36302411-5052E9B2-10E5-4111-B48D-B9ACB69C4E95Q36333463-A17FE697-CD5D-41D1-9B9E-C08AFC97E219Q36681454-C9CFC6AB-E138-4498-9036-AFAF2ED89FF9Q36995035-BB6C83C6-CD55-41A5-AD66-F307CDE26B8BQ36998626-C8B531EA-6AE3-40DA-9178-1DF1A74CEFF5Q37138869-B2E3971B-41A2-417E-AF12-AFB3AF06DE3CQ37162567-030BDCF7-2808-4049-8066-3D7447685DA5Q37298704-792E963D-847C-4890-B453-ACF0EA797D6BQ37596531-3C84B5CB-0BC8-4025-8963-980B5FD80F8CQ38813685-6A968D3A-7960-453B-80B3-B9AAF6BF3F5CQ39105761-ACA6E820-679F-422A-8C12-66DD58A6B8A5Q39158676-EB5182CA-9EE4-4A40-A03F-80B8A7D3BDF5Q39195631-E6BFDA2A-110E-4F35-B552-8314DDC99C40Q39905976-FFD61E4F-EFE7-4F99-98D2-E6A1BE29BFADQ40009190-FCB034AB-361B-4A1F-9D39-318AED04D6ABQ40428610-B09D6963-F9DF-49AE-82C8-34B3DFACD7C6Q40629681-547B2B90-3300-47AB-95F7-659ADC46A7BFQ41590646-C0742310-176C-44EC-A32D-3DCAE724FE0FQ42517082-6B4D6977-0812-4E1D-A48B-6BDC368E714AQ42972474-E679648F-6A66-40F6-8719-A1A08E541574Q46054871-06FB5682-C1BC-44E9-9BF9-7C3BA3FE933CQ46484414-6DC3AEC8-6A66-442E-AC2F-5E898ECC5AA6
P2860
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
description
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Februar 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/02/04)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/02/04)
@nl
наукова стаття, опублікована в лютому 2005
@uk
مقالة علمية (نشرت في 4-2-2005)
@ar
name
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@ast
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@en
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@nl
type
label
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@ast
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@en
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@nl
prefLabel
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@ast
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@en
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@nl
P2093
P1433
P1476
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter
@en
P2093
Frances Plane
Kevin Thorneloe
Kuniaki Ishii
Rosalyn Johnson
William Cole
William Wiehler
P304
P356
10.1161/01.RES.0000154070.06421.25
P577
2005-02-04T00:00:00Z